Crossmark

Efficacy and safety of taxane monotherapy in advanced gastric cancer refractory to triplet chemotherapy with docetaxel, cisplatin, and S-1: a multicenter retrospective study

Crossref DOI link: https://doi.org/10.1007/s00280-017-3397-3

Published Online: 2017-07-20

Published Print: 2017-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Iizumi, Sakura https://orcid.org/0000-0001-6760-152X
Takashima, Atsuo https://orcid.org/0000-0002-8456-1248
Narita, Yukiya https://orcid.org/0000-0002-8018-0077
Tajika, Masahiro https://orcid.org/0000-0002-3761-6971
Muro, Kei

Kawai, Sadayuki https://orcid.org/0000-0001-6815-6261
Yasui, Hirofumi

Matsushima, Tomohiro https://orcid.org/0000-0002-6871-8305
Takahari, Daisuke https://orcid.org/0000-0002-2492-6014
Nagashima, Kengo https://orcid.org/0000-0003-4529-9045
Boku, Narikazu https://orcid.org/0000-0002-1438-707X
License Information

License valid from 2017-07-20

Document is current

Any future updates will be listed below